Evaluating the impact of age on immune checkpoint therapy biomarkers
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1929927bbd9e4b6ca3ee96700e38831f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:1929927bbd9e4b6ca3ee96700e38831f |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:1929927bbd9e4b6ca3ee96700e38831f2021-11-18T04:48:05ZEvaluating the impact of age on immune checkpoint therapy biomarkers2211-124710.1016/j.celrep.2021.110033https://doaj.org/article/1929927bbd9e4b6ca3ee96700e38831f2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2211124721015151https://doaj.org/toc/2211-1247Rossin ErbeZheyu WangSharon WuJoanne XiuNeeha ZaidiJennifer LaDavid TuckNathanael FillmoreNicolas A. GiraldoMichael TopperStephen BaylinMarc LippmanClaudine IsaacsReva BashoIlya SerebriiskiiHeinz-Josef LenzIgor AstsaturovJohn MarshallJosephine TavernaJerry LeeElizabeth M. JaffeeEvanthia T. Roussos TorresAshani WeeraratnaHariharan EaswaranElana J. FertigElsevierarticleBiology (General)QH301-705.5ENCell Reports, Vol 37, Iss 7, Pp 110033- (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Biology (General) QH301-705.5 |
| spellingShingle |
Biology (General) QH301-705.5 Rossin Erbe Zheyu Wang Sharon Wu Joanne Xiu Neeha Zaidi Jennifer La David Tuck Nathanael Fillmore Nicolas A. Giraldo Michael Topper Stephen Baylin Marc Lippman Claudine Isaacs Reva Basho Ilya Serebriiskii Heinz-Josef Lenz Igor Astsaturov John Marshall Josephine Taverna Jerry Lee Elizabeth M. Jaffee Evanthia T. Roussos Torres Ashani Weeraratna Hariharan Easwaran Elana J. Fertig Evaluating the impact of age on immune checkpoint therapy biomarkers |
| format |
article |
| author |
Rossin Erbe Zheyu Wang Sharon Wu Joanne Xiu Neeha Zaidi Jennifer La David Tuck Nathanael Fillmore Nicolas A. Giraldo Michael Topper Stephen Baylin Marc Lippman Claudine Isaacs Reva Basho Ilya Serebriiskii Heinz-Josef Lenz Igor Astsaturov John Marshall Josephine Taverna Jerry Lee Elizabeth M. Jaffee Evanthia T. Roussos Torres Ashani Weeraratna Hariharan Easwaran Elana J. Fertig |
| author_facet |
Rossin Erbe Zheyu Wang Sharon Wu Joanne Xiu Neeha Zaidi Jennifer La David Tuck Nathanael Fillmore Nicolas A. Giraldo Michael Topper Stephen Baylin Marc Lippman Claudine Isaacs Reva Basho Ilya Serebriiskii Heinz-Josef Lenz Igor Astsaturov John Marshall Josephine Taverna Jerry Lee Elizabeth M. Jaffee Evanthia T. Roussos Torres Ashani Weeraratna Hariharan Easwaran Elana J. Fertig |
| author_sort |
Rossin Erbe |
| title |
Evaluating the impact of age on immune checkpoint therapy biomarkers |
| title_short |
Evaluating the impact of age on immune checkpoint therapy biomarkers |
| title_full |
Evaluating the impact of age on immune checkpoint therapy biomarkers |
| title_fullStr |
Evaluating the impact of age on immune checkpoint therapy biomarkers |
| title_full_unstemmed |
Evaluating the impact of age on immune checkpoint therapy biomarkers |
| title_sort |
evaluating the impact of age on immune checkpoint therapy biomarkers |
| publisher |
Elsevier |
| publishDate |
2021 |
| url |
https://doaj.org/article/1929927bbd9e4b6ca3ee96700e38831f |
| work_keys_str_mv |
AT rossinerbe evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT zheyuwang evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT sharonwu evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT joannexiu evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT neehazaidi evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT jenniferla evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT davidtuck evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT nathanaelfillmore evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT nicolasagiraldo evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT michaeltopper evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT stephenbaylin evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT marclippman evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT claudineisaacs evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT revabasho evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT ilyaserebriiskii evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT heinzjoseflenz evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT igorastsaturov evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT johnmarshall evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT josephinetaverna evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT jerrylee evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT elizabethmjaffee evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT evanthiatroussostorres evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT ashaniweeraratna evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT hariharaneaswaran evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers AT elanajfertig evaluatingtheimpactofageonimmunecheckpointtherapybiomarkers |
| _version_ |
1718425023833702400 |